|
|
||||||||




* Environmental Biology, School of Medicine, Hokkaido University, Sapporo, Japan;
Laboratory for Immune Regulation,
Laboratory for Lymphocyte Development, and
Developmental Genetics Group, RIKEN, Research Center for Allergy and Immunology, Yokohama-shi, Japan; and
¶ Bioresource Engineering Division, RIKEN, Bioresource Center, Tsukuba, Japan
We have generated a novel mouse model harboring the in-frame rearranged TCRV
specific for invariant NKT (iNKT) cells (V
14-J
18) on one allele by crossing the mouse cloned from NKT cells with wild-type mice. This genomic configuration would ensure further rearrangement and expression of TCRV
14-J
18 under the endogenous promoters and enhancers. Mice harboring such an in-frame rearranged TCRV
(V
14-J
18 mouse) possessed an increase in iNKT cells in the thymus, liver, spleen, and bone marrow. Intriguingly, both Th1- and Th2-type cytokines were produced upon stimulation with
Galactosylceramide, an agonist of iNKT cells, and the IgE level in the serum remained unaffected in the V
14-J
18 mouse. These features markedly distinguish the nature of iNKT cells present in the V
14-J
18 mouse from that of iNKT cells found in the V
14-J
18 transgenic mouse. Besides these, the expression of TCRV
cells remained intact, and the use of the TCRV
repertoire in iNKT cells was highly biased to TCRV
8 in the V
14-J
18 mouse. Furthermore,
Galactosylceramide-CD1d dimer-reactive immature iNKT cells expressed less Rag2 as compared with the conventional immature T cells at the positive selection stage. Cell cycle analysis on the thymocytes revealed that no particular subset proliferated more vigorously than the others. Crossing the V
14-J
18 mouse with the CD1d knockout mouse revealed a novel population of iNKT cells whose coreceptor expression profile was similar to that assigned to iNKT precursor cells. These mice will be useful for the study on the development of iNKT cells as well as on their functions in the immune system.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by RIKEN and in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to A. Ogura).
2 Address correspondence and reprint requests to Dr. Hiroshi Wakao, Environmental Biology, School of Medicine, Hokkaido University N15W7 Sapporo 060-8638 Japan. E-mail address: hwakao{at}med.hokudai.ac.jp
3 Abbreviations used in this paper: iNKT, invariant NKT; DP, double positive;
GalCer,
Galactosylceramide; Tg, transgenic; SP, single positive; DC, dendritic cell; HPRT, hypoxanthine phosphoribosyltransferase; DN, double negative; iIEL, intestinal intraepithelial lymphocyte.
This article has been cited by other articles:
![]() |
H. Wakao, R. Wakao, S. Sakata, K. Iwabuchi, A. Oda, and H. Fujita In vitro induction of natural killer T cells from embryonic stem cells prepared using somatic cell nuclear transfer FASEB J, July 1, 2008; 22(7): 2223 - 2231. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |